002630 — Orient Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for Orient Bio, fiscal year end - March 31st, KRW millions except per share, conversion factor applied.

	2020 March 31st	R2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,351	10,940	58,244	29,396	35,958
Net Total Accounts Receivable
Net Total Receivables	9,337	9,421	6,676	8,210	13,827
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	22,179	29,060	70,498	49,250	58,984
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	37,778	31,321	18,319	15,857	17,463
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	72,105	71,519	104,952	81,050	96,988
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11,424	15,230	13,644	3,892	4,207
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	20,143	22,974	21,764	9,658	11,892
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	51,963	48,545	83,188	71,392	85,096
Total Liabilities & Shareholders' Equity	72,105	71,519	104,952	81,050	96,988
Total Common Shares Outstanding